Cooley LLP advised the underwriters on the offering. The Dutch biotech argenx, which develops antibody drugs to treat autoimmune diseases and cancer, has raised €502M ($557M)…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now